Re‐exposure to immunotherapy in metastatic colon cancer: A case report

Re‐exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs.

Detalles Bibliográficos
Autores principales: Hamre, Tonje Riise, Stougaard, Julie Kristine, Havelund, Birgitte Mayland, Jensen, Lars Henrik, Hansen, Torben Frøstrup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223690/
https://www.ncbi.nlm.nih.gov/pubmed/34194811
http://dx.doi.org/10.1002/ccr3.4349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223690/
https://www.ncbi.nlm.nih.gov/pubmed/34194811
http://dx.doi.org/10.1002/ccr3.4349

Ejemplares similares